Home collection versus publicly funded HIV testing in San Francisco: Who tests where?

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 21, Issue 5, 1999, Pages 417-422

  McQuitty, Mari ^a   McFarland, William ^a,b   Kellogg, Timothy A ^a   White, Edward ^a   Katz, Mitchell H ^a  

^a S Francisco Dept of Public Health   (United States)

^b HIV Seroepidemiology Unit   (United States)

Author keywords

HIV testing; Home Collection testing; San Francisco

Indexed keywords

ADULT; ARTICLE; BISEXUALITY; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0032819314     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199908150-00010     Document Type: Article

References (26)

1. Holtgrave DR, Valdiserri RO, Gerber AR, Hinman AR. Human immunodeficiency virus counseling, testing, referral, and partner notification services. Arch Intern Med 1993;153:1225-30.
2. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
3. Collier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus with saquinavir, zidovudine, and zalcitabine. N Engl J Med 1996;334:1011-7.
4. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society-USA panel. JAMA 1997;277: 1962-9.
5. Egger M, Hirschel B, Francioli P, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. BMJ 1997;315:1194-9.
6. CAESAR Coordinating Committee. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial. Lancet 1997;349:1413-21.
7. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998;279:450-4.
8. McCarthy BD, Wong JB, Munoz A, Munoz A, Frank A, Sonnenberg A. Who should be screened for HIV infection? Arch Intern Med 1993;153:1107-16.
9. Kahn JG. The cost-effectiveness of HIV prevention targeting: how much more bang for the buck? Am J Public Health 1996;86:1709-12.
10. Berrios DC, Hearst N, Coates TJ, et al. HIV antibody testing among those at risk for infection. JAMA 1993;270:1576-80.
11. Centers for Disease Control. HIV counseling and testing - United States, 1993. MMWR 1995;44:169-74.
12. Anderson JE, Hardy AM, Cahill K, Aral S. HIV antibody testing and posttest counseling in the United States: data from the 1989 National Health Interview Survey. Am J Public Health 1992;82: 1533-5.
13. Wortley PM, Chu SY, Diaz T, et al. HIV testing patterns: where, why, and when were persons with AIDS tested for HIV? AIDS 1995;9:487-92.
14. Phillips KA, Coates TJ, Eversley RB, Catania JA. Who plans to be tested for HIV or would get tested if no one could find out the results. Am J Prev Med 1995;11:156-62.
15. Phillips KA, Coates TJ, Catania JA. Predictors of follow-through on plans to be tested for HIV. Am J Prev Med 1997;13:193-8.
16. Irwin K, Olivo N, Schable CA, et al. Performance characteristics of a rapid HIV antibody assay in a hospital with a high prevalence of HIV infection. Ann Intern Med 1996;125:471-5.
17. Spielberg F, Kassler WJ. Rapid testing for HIV antibody: a technology whose time has come. Ann Intern Med 1996;125:509.11.
18. Centers for Disease Control. Update: HIV counseling and testing using rapid tests - United States. MMWR 1998;47:211-5.
19. Home Access Health, available at http://www.homeaccess.com. Accessed August 17, 1998.
20. Branson BM. Home sample collection tests for HIV infection. JAMA 1998;280:1699-1701.
21. San Francisco HIV prevention plan 1997. San Francisco: Harder & Company Community Research, 1996.
22. Frank AP, Wandell MG, Headings MD, Connant MA, Woody G, Michel C. Anonymous HIV testing using home collection and telemedicine counseling. Arch Intern Med 1997;157:309-14.
23. Stata Statistical Software: release 5.0. College Station, TX: Stata Corporation, 1997.
24. Katz MH, McFarland W, Guillin V, et al. Continuing high prevalence of HIV and risk behaviors among young men who have sex with men: The Young Men's Survey in the San Francisco Bay Area in 1992 to 1993 and in 1994 to 1995. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:178-81.
25. Centers for Disease Control and Prevention. National HIV prevalence surveys, 1997 summary. Atlanta: Centers for Disease Control and Prevention, 1998:1-25.
26. Valdiserri RO, Weber JT, Frey R4 Trends in HIV seropositivity in publicly funded HIV counseling and testing programs: implications for prevention policy. Am J Prev Med 1998;14:31-42.